Is persistent hypotension after transient cardiogenic shock associated with an inflammatory response?

Brazilian Journal of Medical and Biological Research

Volumn 41, Issue 8, 2008, Pages 648-656

  Park, M ^a,b,d   Maciel, A T ^a,b   Noritomi, D T ^a,b   Brunialti, M K ^c   Salomao R ^c   Schettino, G P P ^a   Azevedo, L C P ^a,b  

^a HOSPITAL SÍRIO LIBANÊS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d NONE   (Brazil)

Author keywords

Cardiac tamponade; Cardiogenic shock; Inflammation; Myocardial dysfunction; Swine; Systemic inflammatory response syndrome

Indexed keywords

INTERLEUKIN 6; LACTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBON DIOXIDE TENSION; CARDIOGENIC SHOCK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; CORE TEMPERATURE; FEMALE; HEART INDEX; HEART LEFT VENTRICLE WORK; HEART TAMPONADE; HYPERLACTATEMIA; HYPOTENSION; ILEUM; INFLAMMATION; METABOLIC ACIDOSIS; MYOCARDIAL DISEASE; NONHUMAN; OLIGURIA; PATHOGENESIS; PERFUSION; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; SWINE; TACHYCARDIA;

ANIMALIA; PIERIS BRASSICAE; SUIDAE;

EID: 52949086119     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2008000800002     Document Type: Article

References (24)

1. Hasdai D, Topol EJ, Califf RM, Berger PB, Holmes DR Jr. Cardiogenic shock complicating acute coronary syndromes. Lancet 2000; 356: 749-756.
2. Hochman JS. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 2003; 107: 2998-3002.
3. Cotter G, Kaluski E, Milo O, Blatt A, Salah A, Hendler A, et al. LINCS: L-NAME (a NO synthase inhibitor) in the treatment of refractory cardiogenic shock: a prospective randomized study. Eur Heart J 2003; 24: 1287-1295.
4. Cotter G, Kaluski E, Blatt A, Milovanov O, Moshkovitz Y, Zaidenstein R, et al. L-NMMA (a nitric oxide synthase inhibitor) is effective in the treatment of cardiogenic shock. Circulation 2000; 101: 1358-1361.
5. Alexander JH, Reynolds HR, Stebbins AL, Dzavik V, Harrington RA, Van de Werf F, et al. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. JAMA 2007; 297: 1657-1666.
6. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK. N Engl J Med 1999; 341: 625-634.
7. Sanborn TA, Sleeper LA, Bates ER, Jacobs AK, Boland J, French JK, et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 2000; 36: 1123-1129.
8. Dens J, Dubois C, Ector H, Desmet W, Janssens S. Survival of patients treated with intra-aortic balloon counterpulsation for cardiogenic shock in a tertiary centre: variables correlated with death. Eur J Emerg Med 2003; 10: 213-218.
9. Carnendran L, Abboud R, Sleeper LA, Gurunathan R, Webb JG, Menon V, et al. Trends in cardiogenic shock: report from the SHOCK Study. The SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? Eur Heart J 2001; 22: 472-478.
10. Kitashiro S, Sugiura T, Tamura T, Izuoka T, Miyoshi H, Saito D, et al. Factors associated with increased extravascular lung water in cardiac tamponade and myocardial ischemia. Crit Care Meal 1999; 27: 2229-2233.
11. Kohsaka S, Menon V, Lowe AM, Lange M, Dzavik V, Sleeper LA, et al. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med 2005; 165: 1643-1650.
12. Geppert A, Dorninger A, Delle-Karth G, Zorn G, Heinz G, Huber K. Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction. Crit Care Med 2006; 34: 2035-2042.
13. Nordhaug D, Steansrud T, Aghajani E, Korvald C, Myrmel T. Nitric oxide synthase inhibition impairs myocardial efficiency and ventriculo-arterial matching in acute ischemic heart failure. Eur J Heart Fail 2004; 6: 705-713.
14. Hannon JP, Bossone CA, Wade CE. Normal physiological values for conscious pigs used in biomedical research. Lab Anim Sci 1990; 40: 293-298.
15. Hannon JP, Bossone CA, Rodkey WG. Splenic red cell sequestration and blood volume measurements in conscious pigs. Am J Physiol 1985; 248: R293-R301.
16. Hoit BD, Gabel M, Fowler NO. Influence of splenectomy on hemodynamics during cardiac tamponade. Am J Physiol 1991; 261: R907-R911.
17. Ginosar Y, Pizov R, Sprung CL. Arterial and pulmonary artery catheters. In: Parrillo JE, Bone RC (Editors), Critical care medicine: Principles of diagnosis and management. St. Louis: Mosby-Year Book, Inc.; 1995. p 25-49.
18. Geppert A, Steiner A, Zorn G, Delle-Karth G, Koreny M, Haumer M, et al. Multiple organ failure in patients with cardiogenic shock is associated with high plasma levels of interleukin-6. Crit Care Med 2002; 30: 1987-1994.
19. Lluch S, Moguilevsky HC, Pietra G, Shaffer AB, Hirsch LJ, Fishman AP. A reproducible model of cardiogenic shock in the dog. Circulation 1969; 39: 205-218.
20. Hollenberg SM. Cardiogenic shock. Crit Care Clin 2001; 17: 391-410.
21. Lim N, Dubois MJ, De Backer D, Vincent JL. Do all nonsurvivors of cardiogenic shock die with a low cardiac index? Chest 2003; 124: 1885-1891.
22. Brunkhorst FM, Clark AL, Forycki ZF, Anker SD. Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: the potential importance of bacterial translocation. Int J Cardiol 1999; 72: 3-10.
23. Rudiger A, Singer M. Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med 2007; 35: 1599-1608.
24. Moeniralam HS, Bemelman WA, Endert E, Koopmans R, Sauerwein HP, Romijn JA. The decrease in nonsplenic interleukin-6 (IL-6) production after splenectomy indicates the existence of a positive feedback loop of IL-6 production during endotoxemia in dogs. Infect Immun 1997; 65: 2299-2305.